20 Jan 2023
Expressions of interest to join the Australian Technical Advisory Group on Immunisation
We are seeking expressions of interest to fill 7 vacancies on the Australian Technical Advisory Group on Immunisation (ATAGI), commencing 1 July 2023. Consider applying if you are a clinical professional, researcher, service delivery expert or consumer expert
20 Jan 2023
Expressions of interest to join the Australian Technical Advisory Group on Immunisation
We are seeking expressions of interest to fill 7 vacancies on the Australian Technical Advisory Group on Immunisation (ATAGI), commencing 1 July 2023. Consider applying if you are a clinical professional, researcher, service delivery expert or consumer expert
20 Jan 2023
Expressions of interest to join the Australian Technical Advisory Group on Immunisation
We are seeking expressions of interest to fill 7 vacancies on the Australian Technical Advisory Group on Immunisation (ATAGI), commencing 1 July 2023. Consider applying if you are a clinical professional, researcher, service delivery expert or consumer expert
16 Mar 2023
Discovering an Australian antiviral drug for COVID-19
In 2020, 5 Australian research organisations with expertise in infectious diseases and 2 industry partners formed a consortium. Their aim: to produce an Australian antiviral drug for COVID-19. This research is growing Australia’s ability to discover, test, and manufacture antiviral drugs
16 Mar 2023
Discovering an Australian antiviral drug for COVID-19
In 2020, 5 Australian research organisations with expertise in infectious diseases and 2 industry partners formed a consortium. Their aim: to produce an Australian antiviral drug for COVID-19. This research is growing Australia’s ability to discover, test, and manufacture antiviral drugs
16 Mar 2023
Discovering an Australian antiviral drug for COVID-19
In 2020, 5 Australian research organisations with expertise in infectious diseases and 2 industry partners formed a consortium. Their aim: to produce an Australian antiviral drug for COVID-19. This research is growing Australia’s ability to discover, test, and manufacture antiviral drugs
13 Jan 2023
Mandatory reporting of Japanese encephalitis virus vaccines to the Australian Immunisation Register began on 21 December 2022
From 21 December 2022, vaccination providers must report all Japanese encephalitis virus (JEV) vaccines administered to the Australian Immunisation Register (AIR).
13 Jan 2023
Mandatory reporting of Japanese encephalitis virus vaccines to the Australian Immunisation Register began on 21 December 2022
From 21 December 2022, vaccination providers must report all Japanese encephalitis virus (JEV) vaccines administered to the Australian Immunisation Register (AIR).
13 Jan 2023
Mandatory reporting of Japanese encephalitis virus vaccines to the Australian Immunisation Register began on 21 December 2022
From 21 December 2022, vaccination providers must report all Japanese encephalitis virus (JEV) vaccines administered to the Australian Immunisation Register (AIR).
09 Jan 2023
Therapeutic Goods Administration Adj. Professor John Skerritt's interview on ABC Radio National on 9 January 2023
Read the transcript of Therapeutic Goods Administration Adjunct Professor John Skerritt's interview with Hamish Macdonald on ABC Radio National on 9 January 2023
